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Summary.-Experiments are described in which dose-response data have been
obtained for EMT6 mouse tumour cells growing in vivo and exposed to various
cytotoxic agents. A comparison has been made of the response of solid tumours
in the flank and of rapidly growing lung nodules. The results are discussed with
regard to their cell kinetic implications and compared with our results for the
chemosensitivity of EMT6 cells in exponential and plateau phase growth in vitro.
THERE have been several recentstudies
in, which various groups of workers have
compared the sensitivity to cytotoxic
drugs of mammalian cells during the
exponential and plateau phases ofgrowth.
(Barranco, Novak and Humphrey, 1973;
Barranco and Novak, 1974; Twentyman
and Bleehen, 1975a, b; Hahn, Gordon and
Kurkjian, 1974; Ray et al., 1973). The in-
terest in this type of study has been
based on the fact that certain similari-
ties exist between the cell proliferation
kinetics of plateau phase cultures and
the kinetics ofexperimental solid tumours
(Hahn and Little, 1972). Many of the
results obtained have been conflicting
and this has made it difficult to draw
any useful implication for tumour
therapy from the data obtained. It has,
amongst other things, been difficult to
know to what extent the results are
determined by cell kinetic differences
between exponential and plateau phase
cultures and to what extent artefacts
of the in vitro situation are involved.
We have therefore carried out experi-
ments to compare the sensitivity to
cytotoxic drugs in vivo of the EMT6
cell line either during rapid exponential
growth in the lungs (Brown, 1974) or
else growing more slowly as a solid flank
tumour. The results of these studies are
reported in this paper.
MATERIALS AND METHODS
The EMT6 cell line may be grown either
in vivo as a solid tumour or in vitro as a
monolayer (Rockwell, Kallman and Fajardo,
1972). In addition, assay of cell survival
following treatment in vivo may be carried
out by in vitro plating. The particular sub-
line of the tumour used in these experiments
was designated EMT6/VJ/AC and was origi-
nally supplied to us by Dr E. Frindel. The
line is maintained by alternating growth as a
solid tumour in vivo, and four passages
in vitro.
For experiments, male Balb/C mice
between 10 and 14 weeks of age were inocu-
lated with cells taken from the second, third
and fourth in vitro passage since removal
from a previous in vivo passage. For solid
flank tumours, 4 x 104 cells were inoculated
intradermally in a volume of 0 05 ml of
complete culture medium. For growth as
lung nodules, 105 cells were injected into the
lateral tail vein in a volume of 0-25 ml of
Hanks' solution. The growth of solid tu-
mours was monitored using calipers. Three
diameters, mutually at right angles, were
measured, and the tumour volume wasSENSITIVITY TO CYTOTOXIC AGENTS OF THE EMT6 TUMOUR IN VIVO
TABLE I. Cytotoxic Agents Studied
Drug name
Adriamycin (ADAM)
Bleomycin (BLM)
Cyclophosphamidle (Cy)
1,3 Bis (2-Chloroethyl)-
1-nitrosourea
(BCNU)
1-(2-Chloroethyl).3-
cyclohexyl- 1-nitroso-
urea (CCNU)
Source
Pharmitalia (UK) Ltd,
Barnet, Englandl
Lundbeck Ltd, Luton, Eng-
land
Ward Blenkinsop Pharma-
ceuticals Ltd, London,
England
U.S. Nationial Cancer Irnst.
U.S. National Cancer Inst.
Method of preparation and administration
Dissolved in sterile water. Injectedc i.p. in a
volume of 0-1 to 0 6 ml
Dissolved in sterile Hanks' solution. Inijected
i.p. in a volume of 0 5 ml
Dissolved in sterile water. Injectedl i.p. in a
volume of 0-1 to 006 ml
Dissolved to 20 mg/ml in absolute ethanol.
Diluted 1: 20 in sterile Hanks' solution.
Injected i.p. in a volume of 0 15 to 0-8 ml
Suspendled in 0-50o/ carboxymethyl cellulose.
MIixedl for 5 min on a laboratory blender.
Injected i.p. in a volume of 0-15 to 0-8 ml
calculated according to the equation derived
by Watson (1976).
Preparation of a single cell suspension
from solid tumours and in vitro assay for
surviving fraction wvas carried out as pre-
viously described (Twentyman and Bleehen,
1974, 1975c). For lung nodules, the method
was virtually identical except that for
each complete set of lungs a volume of
15 ml of trypsinized Hanks' solution was
used because of the greater mass of tissue
involved.
In order to obtain the growth curve
for lung nodules, lungs were removed from
mice at various times after inoculation of 105
cells and various proportions of each set
of lungs were plated out. From the number
of colonies produced in vitro, it was possible
to obtain a value for " dish colonies/set of
lungs ". From Day 8 onwards, the number
of EMT6 cells in the cell suspension was
sufficiently large to enable a haemacytometer
count to be performed. The tumour cells
were very easily distinguishable from the
much smaller lung cells.
TwNo experiments were carried out in
which much smaller numbers of EMT6
cells wvere given intravenously to groups
of 6 mice and allowed to develop for 14 days
in the lungs. At the end of this time, the
lungs were removed, fixed in Carnoy fluid
and the lung nodules counted. An experi-
ment was also carried out in wbich various
proportions of normal lungs wvere plated out
with a fixed number of tumour cells in order
to see wrhether the number of colonies
produced in vitro w,vas dependent upon the
number of lung cells present.
Cytotoxic drugs were obtained, prepared
and administered as shown in Table I.
For dose-response curves, animals wvere
killed at 2 h after drug administration.
For time-response curves, times of 30 min,
2 h and 6 h were used. All experiments
were carried out at 9 or 10 days following
inoculation of tumour cells. Each point
in the figures represents a separate deter-
mination using pooled cells from two mice
with tumours of similar size (for flank
tumours) or at the same time after inoculation
(for lung nodules).
RESULTS
Growth offlank tumours (Fig. 1)
A typical growth curve obtained
during the recent series of experiments
is shown. This is for a group of 8 mice.
The tangent to the curve at 9-5 days after
inoculation gives a tumour doubling time
of around 44 h. This figure is very
similar to the value of 46 h which has
been estimated from an earlier growth
curve obtained for this tumour sub-line
and based on 40 animals.
Growth of lung nodules (Fig. 2)
The growth curve for number of dish
colonies per set of lungs is shown in
Figure 2, and is based on results for
individual mice in 4 separate experiments.
In individual experiments, the curve was
exponential until at least Day 12. Most
animals allowed to remain intact died
on Days 14-16. It is interesting to
note that on Days 8-12, when tumour
cells could be counted on a haemacyto-
meter, a relationship between cells plated
and dish colonies produced gave a plating
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Ft(. 1. Increase in volume of EMT6 flank
tumours with time after inoculation of
4 x 104 cells. Poinlts indicate mean volume
for a group of 8 mice and errors shown
are the standardl error of the mean.
efficiency of 30-5000. This is similar to
our typical value for cells obtained from
solid tumours. If it is assumed that
the cell yield of our trypsinization method
is the same for nodules of all sizes (and
we have no reason to believe otherwise),
then the line drawn through the points
in Figure 2 indicates a doubling time of
17*6 h for the tumour cell population in
the lungs. This value is similar to the
measured cell cycle time within the
proliferating compartment of EMT6 solid
tumours. Rockwell et al. (1972) obtained
a value of 20*7 h for tumours of 200 mm3
volume, and Watson (1976) studying
tumours ranging from 1*5 to 175 mm3
obtained a range of cycle times from 14
to 18-5 h. It therefore appears likely
that our figure of 17*6 h represents the
approximate cycle time of an exponenti-
ally growing cell population with a growth
fraction of near to 100%. We are cur-
to5~
a
._2 Is 0
._
0
(s)
(6)
(5) (2)
(7) i
Cs)
2 4 6 8 10 12 14
Days after Inoculation
FIG. 2. Increase in dish colonies per set
of lungs plated with time after inoculation
of 105 EMT6 cells into the tail vein.
Data shown are from 4 separate experi-
ments. Points indicate the mean valtue
for the number of mice shown in paren-
theses. Error bars show the standar(d
error of the mean.
rently carrying out a cell kinetic analysis
ofnodule growth using tritiated thymidine
autoradiography.
Lung nodules/cell inoculated
In the first experiment where 104 cells
were inoculated, the number of lung
nodules produced was 37.7 + 2*5 (one
standard error). In the second experi-
ment, where 2 x 103 cells were inoculated,
the number of nodules was 4.8 + 0.6.
These results give figures of 377 and 240
nodules per 105 cells inoculated re-
spectively. The mean value is therefore
around 300 nodules per 105 cells. From
Figure 2 it may be seen that at Days
9-10 after inoculation of 105 cells, around
106 dish colonies were obtained per set of
lungs. If a value of 30-350 is assumed
for the plating efficiency, then the number
322
le 4SENSITIVITY TO CYTOTOXIC AGENTS OF THE EMT6 TUMOUR IN [V )l' :
of tumour cells is around 3 x 106 per
set of lungs. By dividing this figure by
300 (the number of nodules per 105 cells
inoculated), we obtain a value of about
103 cells per nodule at the time at which
experiments were performed. This im-
plies a nodule diameter of 120-150 ,im at
this time.
Effect of lung cells on plating of tumour
cells
It was found that the number of
colonies produced in vitro by 300 tumour
cells plated did not vary with the addition
of between 0.01% and 10% of one set
of lungs per dish. At 1000, however,
there was a light overgrowth of fibroblasts
which made the counting of colonies
more difficult. A later test showed that
at 20% of a set of lungs/dish the dense
fibroblast layer made identification of
colonies difficult. In experiments, there-
fore, 1000 of one set of lungs/dish has
been regarded as the upper acceptable
limit in determining the survival of
tumour cells at low surviving fractions.
Response to cytotoxic drugs
Bleomycin (BLM).-We have previ-
ously shown (Twentyman and Bleehen,
1974) that for the EMT6 solid tumour
over a wide range of sizes, the 2 h dose-
response curve has virtually reached a
plateau of survival at 1 mg/kg and that
this plateau continues until at least
10 mg/kg. Furthermore, we have also
shown that tumours of all sizes appear to
" repair potentially lethal damage " if
assay is delayed until 24 h following
drug administration. More recently, we
have shown that the measured surviving
fraction is at a minimum about 30 min
after BLM administration and that " re-
pair " is virtually complete by 6 h (Twen-
tyman and Bleehen, 1975c). In the
current series of experiments we have,
therefore, chosen a dose ofBLM (4 mg/kg)
which is well on to the plateau of the
dose-response curve and examined the
time response of the solid tumour and
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FIG. 3. Change in surviving fraction of
EMT6 cells with time after administration
of BLM (4 mg/kg). Closed symbols flank tumours. Open symbols lung nodules. The line is drawn to fit the
closed symbols only. Errors within indi-
vidual experiments are small comparedl vith the sprea(d ofresuilts between different
experiments (except, at the 6 h point wvhere a typical 2 x standard erior bar is
shown).
oflung nodules to this dose. The results
are shown in Fig. 3. The responses of the two systems show very similar
patterns. Mean surviving fractions at
30 min are about 4 x 10-3 for solid
tumours and 1*3 x 10-2 for lung nodules.
By 6 h the values have recovered to
around 9000 and 3000 respectively.
Adriamycin (ADM). For each of the
remaining agents we were anxious to
ascertain that the " repair of potentially lethal damage " phenomenon did not
operate in such a way as to dictate the
time that should be used for a dose-
response curve. Preliminarytime-response
curves for the solid tumour were therefore
obtained for each agent. For ADM
(60 mg/kg) little decrease in surviving
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FIG. 4. Change in surviving fraction of
EMT6 cells with dose of ADM adminis-
tered 2 h previously. Closed symbols
flank tumours. Open symbols lung no-
dules. The line is drawn to fit the closed
symbols only. Errors within individual
experiments are small compared with the
spread of results between different ex-
periments.
fraction is seen at any time. The 2 h
dose-response curves for solid tumour and
lung nodules are shown in Fig. 4. Again,
there is little effect on the solid tumour at
any dose. The effect on lung nodules
appears to be slightly greater although,
even at the highest doses used, the
mean surviving fraction is still around
30%.
Cyclophosphamide (Cy). A time-re-
sponse curve for this agent was carried
out at a dose of 60 mg/kg. The mean
surviving fraction was a little lower at
2 h than at 30 min or 6 h but not signifi-
cantly so, given the spread of values
obtained. The 2 h dose-response curves
are shown in Fig. 5. There is apparently
no significant difference between the
response of lung nodules and the solid
tumour.
FIG. 5. Change in surviving fraction ofEMT6
cells with dose of Cy administered 2 h
previously. Closed symbols flank tu-
mours. Open symbols lung nodules.
The line is drawin to fit the closed symbols
only. Errors within individual experi-
ments are small compared with the
spread of results between different ex-
periments.
BCNU. Following a single dose of
BCNU (6 mg/kg) the surviving fractions
measured at 2 h and 6 h are similar, and
generally lower than the 30 min values.
The 2 h dose-response curves are shown
in Fig. 6. The responses are similar
although there is perhaps a trend towards
a slightly greater response for lung
nodules at higher doses.
CCNU.-The time-response curve for
this agent was carried out at a dose
of 20 mg/kg. The mean value of sur-
viving fraction observed at 6 h was similar
to the 2 h value, and much lower than
the surviving fraction at 30 min. The
2 h dose-response curves are shown in
Fig. 7. There is a very wide spread of
results for this agent. This is probably
due to the method of drug administration
with consequent variability in drug
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FiG. 6. Change in surviving fraction of
EMTO cells with dose of BCNU ad-
ministered 2 h previously. Closed sym-
bols flank tumours. Open symbols lung
nodules. The line is drawn to fit the closed
symbols only. Errors within individual
experiments are small compared with the
spread of results between different ex-
periments.
absorption. Again it does not appear that
there is any significant difference in the
response of the two systems.
DISCUSSION
Before consideration of any cell kinetic
implications of our results it is necessary
to point out that the cells under study
in our two systems are not exposed to
uniform concentrations of drugs. It is
difficult to make realistic estimates of
how drug concentrations will vary but
it is generally accepted that there are
populations of cells in solid tumours
which are relatively distant from blood
vessels and hence less accessible to sub-
stances dissolved in the blood stream.
Should uneven drug availability be a
Dose (mg/kg)
Fic. 7. Change in surviving fraction of
EMT6 cells with dose of CCNU adminis-
tered 2 h previously. Close(d symbols
flank tumours. Open symbols-lung
nodules. The line is drawn to fit the
closed symbols only. Errors within indivi-
dual experiments are small compared with
the spread of results between different
experiments.
factor in these studies, therefore, it would
probably be expected to be shown by
the presence of a resistant fraction of
cells in the solid flank tumours.
Bleomycin. Interpretation of BLM
response curves where cell survival is
assayed by transplantation techniques is
extremely difficult because of the opera-
tion of the effect usually referred to as
" repair of potentially lethal damage ".
We have discussed this effect fully in a
recent publication (Twentyman and Blee-
hen, 1975c). What is very obvious from
the results, however, is that this effect
operates to nearly the same extent in
lung nodules as it does in the solid tumour.
If, therefore, this effect of delayed sub-
culture in vivo operates via the same
mechanism as that in vitro, our finding
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would agree wvith the observation that
the ability to repair potentially lethal
damage is possessed by both exponential
and plateau phase cells in vitro (Barranco
et al., 1975; Twentymain and Bleehen,
1975c) rather than being confined to
plateau phase cells (Ray et al., 1973).
The results reported here are consistent
with our observation (Twentyman and
Bleehen, 1973) that proliferating spleen
colony-forming cells in mouse marrow are
more sensitive than are quiescent CFUs
to BLM when assay is carried out at
24 h after drupg administration, although
it is possible that a different conclusion
may have been reached had the assay
been performed at a different time.
Adriamnycin. Our previously reported
results for the response of exponential
and plateau phase cells in vitro to ADM
(Twentyman and Bleehen, 1 975b) are
similar to those reported by Barranco
a(ndl Novak (1974). The response for
exponential phase cells is very rapid,
fallfing to 10-3 for a dose of 1 pg/ml for
1 h, whereas the response of plateau
phase cells is very much less, the surviving
fraction being in excess of 10-1 at 1 /ig/ml.
If these in vitro r-esults could be directly
applied to the in vivo situation, then
one wotuld expect the dose-response curves
for lung nodules aind solid tumours to be
very different. In fact, both systems
are extremely insensitive to even very
hiigh doses of this agent. This could,
of course, be due to the druig not reaching
the cells wheni given by the i.p. route.
However, Hahn, Brauii and Har-Kedar
(1975) have found the response of the
EMT6 tumour to adriamycin to be only a
little increased if the drug is givein by the
intravenous instead ofthe intraperitoneal
route. Furthermore, these authors found
that the respoInse cani be extremely severe
if the tumour is heated, due, at least in
part, to increased penetration ofdrug into
the cell. It wotuld therefore appear that
aiccess of ADM into the cell is the problem
here rather than availability of drug in
the extracellular environment. If this
is so, theni the very rapid response shown
by exponential cells in vitro appears not
to be reflected in vivo and may be only
indicative ofthe state ofthe cell membrane
during this particular phase of in vitro
growth.
Cyclophosphamide. Our results sug-
gest that there is no great change in the
measured surviving fraction between 2
and 6 h following administration of Cy.
It appears therefore that for the purposes
of our present study, a time of 2 h after
drug administration is appropriate for
comparison of dose-response data. Re-
pair of potentially lethal drug damage
may, however, occur between 6 and
24 h (Hahn et al., 1973).
The dose-response curves for cyclo-
phosphamide do not indicate any differ-
ence in sensitivity between cells in lung
nodules and in solid tumours. This
suggests agreement with the results of
Wharam et al. (1973), who found that
Cy has an equal effect against oxygenated
and hypoxic cells in the EMT6 tumour
and also the recent results of Hill and
Stanley (1975) who reported a similar
finding for the B16 melanoma. Also,
Blackett and Adams (1972) found little
difference in the sensitivity of slowly and
rapidly proliferating cells in the repopulat-
ing compartment of the erythroid series.
On the other hand Steel aind Adams
(1975) have recently shown that the
response to Cy of small lung nodules of
the Lewis lung carcinoma may be greater
than that of larger tumours, Lin (1973)
showed a marked difference in the re-
sponse of slowly and rapidly proliferating
lymphoid cells to Cy, and van Putten
(1974) has shown a, degree of proliferation
dependence for spleen colony-forming
units in the mouse marrow. It would
therefore appear that the conclusioni
regarding the proliferation dependence of
cyclophosphamide depends greatly upon
the cell type studied. In situations
where repair of potentially lethal damage
may opercate, and probably to different
extenits in the cycling and non-cycling
populations, the conclusions regarding
differential sensitivity may well be
326)SENSITIVITY TO CYTOTOXIC AGENTS OF THE EMT6 TUMOUR 1A' v'I 'v) 327
dependent Upon the timiiig of the experi-
ment. It seems, however, that the anoxic
(and probably non-cycling) compartment
of cells in solid tumours probably does
not represent a population resistant to
this drug.
BCNU. The data of Barranco et
al. (1975) indicate that in vitro there is
no recovery from potentially lethal damage
by cells treated with this agent. Our in
vivo data (Fig. 7) and those of Hahn et
al. (1974) support this idea. The dose-
response curve we have obtained for the
solid tumour appears to be almost ex-
ponential down to a surviving fraction
of 10-4 at a dose of 25-30 mg/kg. This
is similar in shape but a little more steep
than the curve obtained for the B16
melanoma by Hill and Stanley (1975).
On the other hand, in a recent study of
the respoinse to BCNU of cells in a trans-
planted braiintumourintherat,Rosenblum
et al. (1975) found a very resistant fraction
of about 10-3 of the total population.
Also, in a study of the P815X2 masto-
cytoma in the mouse, the tumour cells
were found by Hagemann, Schenken and
Lesher (1973) to be very resistant to
BCNU, and the authors suggest that
drug availability is the likely cause.
Otur data for lung nodules suggest a
response curve which is perhaps a little
steeper than that for the solid tumour.
It would appear therefore, that in our
solid tumour system, there is no large
populatioin of cells which is resistant
to BCNU for ainy reason. Furthermore,
the sensitivity of the cycling and non-
cycling compartment appears to be simi-
lar. This is in agreement with our find-
ings that EMT6 cells growing in vitro
show similar sensitivity to BCNU in
the exponiential, early plateau and late
plateau phases of growth (Twentyman
and Bleehen, 1975b). The data for other
tumours, however, indicate that our
findings may not apply to all such
systems.
CCONU. Absence of repair of poten-
tially lethal da,mage observed for CCNU
in our system is in agreement wvith
the findings in vitro of Barraanco et al.
(1975). Again, the sensitivity of EMT6
cells in solid tumours and in lung nodules
appears to be similar with no evidence
for the presence of a resistant fraction
in the solid tumour. This result is in
agreement with that of Hill and Stanley
(1975) for the B16 melanoma, and also
with our in vitro results for EMT6 cells
in exponential aand plateau phase (Twenty-
man and Bleehen, 1975b).
In general, therefore, in our system
there does not seem to be much difference
in the response of lung nodules and
solid tumours to any of the agents
studied. This is in contrast to the
results of Conzelman and Springer (1969)
who found that the SAHi -1 mouse
tumour was more sensitive to several
drugs when growing subcutaneously than
when growing in the lungs.
The results presented in the present
paper, notably those for ADM, further
emphasize a point we have made in
previous publications, i.e. it is dangerous
to extrapolate results obtained in one
experimental situation to another situa-
tion. This applies both to extrapolation
from one cell line to another in vitro
and to extrapolation from the in vitro to
the in vivo situation for the same cell
line. Before such comparisons caIn legi-
timately be made, we need to know
much more about the factors both kinetic
and otherwise which determine the re-
sponse of cells to cytotoxic drugs.
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